Comparing Calibration Technologies for Liquid-Handling Quality Assurance - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Comparing Calibration Technologies for Liquid-Handling Quality Assurance
The authors consider several common techniques for verifying the accuracy of liquid-handling equipment and offer guidance for finding the appropriate technique for a given instrument.


Pharmaceutical Technology
Volume 32, Issue 8

Electrostatic effects also cause uncertainty with gravimetric methods because plastic pipette tips are typically used to transfer liquids. The static electricity that is imparted to the balance pan or the draft shield induces a force that affects measurement accuracy. When working with small volumes, the error can be significant. Vibration must also be controlled for, often by calibrating the instrument in a controlled environment on a solid marble bench.

Because gravimetric measurements calculate volume by converting weight to mass and then to volume, accurate calibration is contingent on knowing the density of the fluid being pipetted. Many laboratory technicians assume the fluid being measured has the density of 1 g/mL, which is the approximate density of water. Although common solutions do have published density values, the densities are not always known to a high degree of accuracy.

To illustrate the possible uncertainty, consider dimethyl sulfoxide (DMSO). Its published density is 1.1 g/mL. The density is published with limited resolution, using only two significant figures. In addition, the density of DMSO changes according to its water content, which depends on the starting water content and the time it is exposed to ambient local temperature and relative humidity. Even the density of water varies with temperature and, at room temperature, is always less than 1 g/mL, its commonly accepted value.

These details must be accounted for if precise measurements are required. Consider a device with accuracy specifications of better than 0.6%, which is a typical specification for high-accuracy pipetting of 1000 μL. Failure to correct for density errors, even when pipetting water, can lead to error in the 0.3–0.5% range, which is nearly as large as the acceptable error for the entire piece of equipment. When acceptable tolerances are in the 5–10% range, however, density considerations are much less important.

An alternative to referring to published density values is to measure density with a commercial densitometer or pycnometer. For reliable results, these instruments require calibration as other laboratory instruments do. Care must be taken to avoid measurement error.

One last drawback of gravimetry is its inability to simultaneously measure each individual channel in multichannel liquid-handling devices. With gravimetry, individual aliquots can be measured or multiple dispenses may be made and the total weight used to calculate the average volume. To measure the performance of single channels, each channel must be tested one tip at a time. This process is time-consuming and tedious. Testing each channel one time in a 96-channel device, for example, would require 96 dispenses.

In summary, gravimetric calibration is best suited to measuring the performance of single-channel devices that handle large liquid volumes, usually those above 200–1000 μL. The precise lower limit for effective use of gravimetry depends on the tightness of the tolerance to be met and the quality of the measuring equipment and procedure used.

Fluorometry

During fluorometric calibration, a beam of ultraviolet light is shone on a sample at one wavelength, called the excitation wavelength. This exposure causes the molecules to absorb light and enter an excited electronic state. Release of this excess energy results in the emission of light at a different, longer wavelength, called the emission wavelength. A detector is used to measure how much light is emitted at the emission wavelength. Precision is measured by comparing relative fluorescence levels in different samples.

Fluorescent dyes are photoactive and generate a strong signal at low volumes. Small samples can generate large signals at low concentrations, which facilitates fluorometry's use in measuring small volumes. Measurements of volumes as small as 5 nL are possible.

A major drawback of fluorometry is the difficulty in achieving robust traceability, which often prevents its use in regulated laboratories. This deficiency results from the fact that the strength of the fluorescent measuring signal varies depending on the local chemical environment. Factors such as solvent composition, pH, ionic strength, redox potential, and time can alter the signal strength. For this reason, during a given measurement, the volume in a well can be compared with a volume in the previous well, provided that all volumes have similar chemical compositions. It is difficult, however, to compare measurement readings day-to-day, assay-to-assay, or location-to-location unless traceability is established. Traceability is typically established by developing a standard response curve using a calibrated pipette or other traceable liquid-delivery device.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Source: Pharmaceutical Technology,
Click here